Prominence of cell-mediated immunity effectors in 'pauci-immune' glomerulonephritis

Journal of the American Society of Nephrology

Volumn 10, Issue 3, 1999, Pages 499-506

  Cunningham, Malcolm A ^a,b   Huang, Xiao Ru ^a   Dowling, John P ^a   Tipping, Peter G ^a   Holdsworth, Stephen R ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FIBRIN FORMATION; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNE INJURY; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOLOGY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; T LYMPHOCYTE ACTIVATION;

EID: 0344076302     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Jennette JC, Falk RJ: The pathology of vasculitis involving the kidney. Am J Kidney Dis 24: 130-141, 1994
2. Glassock RJ: A clinical and immunopathologic dissection of rapidly progressive glomerulonephritis. Nephron 22: 253-264, 1978
3. Bolton WK, Innes DJ Jr, Sturgill BC, Kaiser DL: T-cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathologic correlations. Kidney Int 32: 869-876, 1987
4. Bhan AK, Schneeberger EE, Collins AB, McCluskey RT: Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med 148: 246-260, 1978
5. Atkins RC, Holdsworth SR, Glasgow EF, Matthews FE: The macrophage in human rapidly progressive glomerulonephritis. Lancet 1: 830-832, 1976
6. Imamura T, Iyama K, Takeya M, Kambara T, Nakamura S: Role of macrophage tissue factor in the development of the delayed hypersensitivity reaction in monkey skin. Cell Immunol 152: 614-622, 1993
7. Colvin RB, Mosesson MW, Dvorak HF: Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack of fibrin deposition and induration. J Clin Invest 63: 1302-1306, 1979
8. Bolton WK, Tucker FL, Sturgill BC: New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity: Nonhumorally mediated glomerulonephritis in chickens. J Clin Invest 73: 1263-1276, 1984
9. Huang XR, Tipping PG, Apostolopoulos J, Oettinger C, D'Souza M, Milton G, Holdsworth SR: Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol 109: 134-142, 1997
10. Huang XR, Holdsworth SR, Tipping PG: Evidence for delayed type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46: 69-78, 1994
11. Holdsworth SR, Neale TJ, Wilson CB: Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit: Use of an antimacrophage serum. J Clin Invest 68: 686-698, 1981
12. Huang XR, Tipping PG, Li S, Holdsworth SR: Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 51: 94-103, 1997
13. Tipping PG, Thomson NM, Holdsworth SR: A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol 67: 481-491, 1986
14. Thomson NM, Simpson IJ, Peters DK: A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis. Clin Exp Immunol 19: 301-308, 1975
15. Vassalli P, McCluskey RT: The pathogenic role of the coagulation process in rabbit Masugi nephritis. Am J Pathol 45: 653-677, 1964
16. Li S, Holdsworth SR, Tipping PG: Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int 51: 672-678, 1997
17. Tipping PG, Erlich JH, Apostolopoulos J, Mackman N, Loskutoff D, Holdsworth SH: Glomerular tissue factor expression in crescentic glomerulonephritis: Correlations between antigen, activity, and mRNA. Am J Pathol 147: 1736-1748, 1995
18. Erlich JH, Holdsworth SR, Tipping PG: Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis [see comments]. Am J Pathol 150: 873-880, 1997
19. Erlich JH, Apostolopoulos J, Wun TC, Kretzmer KK, Holdsworth SR, Tipping PG: Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest 98: 325-335, 1996
20. Stilmant MM, Bolton WK, Sturgill BC, Couser WG: Crescentic glomerulonephritis without immune deposits: Clinicopathologic features. Kidney Int 15: 184-195, 1979
21. Charles LA, Falk RJ, Jennette JC: Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol 53: 243-253, 1989
22. Jensen EB, Gundersen HJ, Osterby R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115: 19-33, 1979
23. Wilson CB, Dixon FJ: The renal response to immunological injury. In: The Kidney, edited by Brenner BM, Rector FC, Philadelphia, Saunders, 1981, pp 1237-1350
24. Thomson NM, Moran J, Simpson IJ, Peters DK: Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int 10: 343-347, 1976
25. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31: 964-972, 1987
26. Jennette JC, Falk RJ, Andrassy K: Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994
27. Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135: 921-930, 1989
28. Rastaldi MP, Ferrario F, Tunesi S, Yang L, D'Amico G: Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1 alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis. Am J Kidney Dis 27: 48-57, 1996
29. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43: 682-692, 1993
30. Lai KN, Lockwood CM: Serum soluble interleukin 2 receptor levels in anti-neutrophil cytoplasmic autoantibodies-positive systemic vasculitis. Postgrad Med J 69: 708-711, 1993
31. Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CG: Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 91: 415-420, 1993
32. Yaqoob M, West DC, McDicken I, Bell GM: Monitoring of endothelial leucocyte adhesion molecule-1 in anti-neutrophil-cytoplasmic-antibody-positive vasculitis. Am J Nephrol 16: 106-113, 1996
33. Lockwood CM, Thiru S, Isaacs JD, Hale G, Waldmann H: Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 341: 1620-1622, 1993
34. Drake TA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am J Pathol 134: 1087-1097, 1989
35. Tipping PG, Dowling JP, Holdsworth SR: Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest 81: 119-125, 1988
36. Nawroth PP, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740-745, 1986
37. Drake TA, Cheng J, Chang A, Taylor FB Jr: Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 142: 1458-1470, 1993
38. De Bandt M, Ollivier V, Meyer O, Babin-Chevaye C, Khechai F, De Prost D, Hakim J, Pasquier C: Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells. Arthritis Rheum 40: 2030-2038, 1997
39. Mayet WJ, Schwarting A, Orth T, Duchmann R, Meyer zum Buschenfelde KH: Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1). Clin Exp Immunol 103: 259-267, 1996
40. King WJ, Adu D, Daha MR: Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 102: 98-105, 1995
41. Griffith ME, Coulthart A, Pusey CD: T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin Exp Immunol 103: 253-258, 1996
42. Heeringa P, Brouwer E, Tervaert JWC, Weening JJ, Kallenberg CCM: Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int 53: 253-263, 1998
43. Brouwer E, Huitema MG, Klok PA, De Weerd H, Tervaert JWW, Kallenberg CG: Antimyeloperoxidase-associated proliferative glomerulonephritis: An animal model. J Exp Med 177: 905-914, 1993
44. Heeringa P, Brouwer E, Klok PA, Huitema MG, Van Den Born, Weening JJ, Kallenberg CCM: Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane mediated glomerular injury. Am J Pathol 149: 1695-1706, 1996